The societal cost of bipolar disorder in Sweden

Social Psychiatry and Psychiatric Epidemiology

Volumn 48, Issue 10, 2013, Pages 1601-1610

  Ekman, Mattias ^a,b   Granström, Ola ^b   Omérov, Sead ^c   Jacob, Johanna ^b   Landén, Mikael ^d,e  

^a OptumInsight   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c Northern Stockholm Psychiatry   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bipolar affective disorder; Burden of illness; Cost; Economics; Resource use

Indexed keywords

ADULT; AMBULATORY CARE; BIPOLAR DISORDER; COST OF ILLNESS; ECONOMICS; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MEDICAL LEAVE; MENTAL HEALTH SERVICE; MIDDLE AGED; PSYCHOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; SWEDEN;

ADULT; AMBULATORY CARE; BIPOLAR DISORDER; COST OF ILLNESS; DIRECT SERVICE COSTS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SICK LEAVE; SOCIOECONOMIC FACTORS; SWEDEN;

EID: 84885431204     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-013-0724-9     Document Type: Article

References (45)

1. Kasper S (2003) Issues in the treatment of bipolar disorder. Eur Neuropsychopharmacol 13(Suppl 2):S37-S42
2. Oswald P, Souery D, Kasper S, Lecrubier Y, Montgomery S, Wyckaert S, Zohar J, Mendlewicz J (2007) Current issues in bipolar disorder: a critical review. Eur Neuropsychopharmacol 17(11):687-695
3. Angst J (1998) The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 50(2-3):143-151
4. Hirschfeld RM, Vornik LA (2005) Bipolar disorder - costs and comorbidity. Am J Manag Care 11(3 Suppl):S85-S90
5. Pini S, de Queiroz V, Pagnin D, Pezawas L, Angst J, Cassano GB, Wittchen HU (2005) Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol 15(4):425-434
6. Kleinman L, Lowin A, Flood E, Gandhi G, Edgell E, Revicki D (2003) Costs of bipolar disorder. Pharmacoeconomics 21(9):601-622
7. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241-251
8. Das Gupta R, Guest JF (2002) Annual cost of bipolar disorder to UK society. Br J Psychiatry 180:227-233
9. de Zelicourt M, Dardennes R, Verdoux H, Gandhi G, Khoshnood B, Chomette E, Papatheodorou ML, Edgell ET, Even C, Fagnani F (2003) Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France. Pharmacoeconomics 21(15):1081-1090
10. Fajutrao L, Locklear J, Priaulx J, Heyes A (2009) A systematic review of the evidence of the burden of bipolar disorder in Europe. Clin Pract Epidemiol Ment Health 5:3
11. Olié JP, Lévy E (2002) Manic episodes: the direct cost of a three-month period following hospitalisation. Eur Psychiatry 17(5):278-286
12. Tafalla M, Salvador-Carulla L, Saiz-Ruiz J, Diez T, Cordero L (2010) Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain. BMC Psychiatry 10:31
13. Ösby U, Tiainen A, Backlund L, Edman G, Adler M, Hällgren J, Sennfält K, van Baardewijk M, Sparen P (2009) Psychiatric admissions and hospitalization costs in bipolar disorder in Sweden. J Affect Disord 115(3):315-322
14. APA (2000) Diagnostic and statistical manual of mental disorders DSM-IV-TR. Text revision. American Psychiatric Association, Washington, DC
15. Hakkaart-van Roijen L, Hoeijenbos MB, Regeer EJ, ten Have M, Nolen WA, Veraart CP, Rutten FF (2004) The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands. Acta Psychiatr Scand 110(5):383-392
16. Begley CE, Annegers JF, Swann AC, Lewis C, Coan S, Schnapp WB, Bryant-Comstock L (2001) The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics 19(5 Pt 1):483-495
17. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosen M (2007) The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16(7):726-735
18. Hodgson TA, Meiners MR (1982) Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc 60(3):429-462
19. Luce BR, Elixhauser A (1990) Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 6(1):57-75
20. SLL (2008) Price list, Stockholm/Gotland. http://extern.bkv.sll.se/samv. sthlm-gotland/. Accessed 2 Aug 2008
21. LUL (2008) Price list, Uppsala-Örebroregionen. http://www.externt9. lul.se/svn/priser06.htm. Accessed 2 Aug 2008
22. LIO (2008) Price list, Sydöstra sjukvårdsregionen. http://www.lio.se/upload/16047/Prislista%202006.pdf. Accessed 2 Aug 2008
23. Norrlandstingen (2008) Price list, Norra sjukvårdsregionen. http://www.norrlandstingen.nu/lankar-prislistor.htm. Accessed 2 Aug 2008
24. SRVN (2008) Price list, Södra Regionvårdsnämnden. http://www.srvn.org/prislista.htm. Accessed 8 Aug 2008
25. VGR (2008) Price list, Västra sjukvårdsregionen. http://www.vgregion.se/upload/svn%20-%20samverkansnämden/ Utomlänspriser%202006%20Västra%20sjukvårdsreg.pdf. Accessed 2 Aug 2008
26. SCB (2010) Price indices. Statistics Sweden. http://www.scb.se/. Accessed 30 Sept 2010
27. TLV (2009) Pharmaceutical Price Database. Dental and Pharmaceutical Benefits Agency. http://www.tlv.se/in-english/price-database/. Accessed 25 Sept 2009
28. SCB (2009) Lönestrukturstatistik. Statistics Sweden. http://www.scb.se/Pages/Product-14364.aspx. Accessed 3 Sept 2009
29. Skatteverket (2009) Socialavgifter för inkomstår 2009. Skatteverket. http://www.skatteverket.se/fordigsomar/arbetsgivareinfotxt/ socialavgifter.4.18e1b10334ebe8bc80005862.html. Accessed 3 Sept 2009
30. SKL (2009) Vad kostar verksamheten i Din kommun? Bokslut 2008. Sveriges Kommuner och Landsting. http://www.skl.se/artikel.asp?C=473&A=61193. Accessed 3 Sept 2009
31. Stadsledningskontoret (2009) Ersättningssystem inom socialpsykiatrin i Stockholm 2009. Stockholm County Council. http://www.skl.se. Accessed 24 Nov 2009
32. SCB (2010) Salary Database. Statistics Sweden (SCB). http://www.scb.se/ Pages/SalariesSearch-259066.aspx. Accessed 26 Jan 2010
33. Skatteverket (2009) Pay-roll taxes. Swedish Tax Agency. http://www.skatteverket.se/foretagorganisationer/forarbetsgivare/socialavgifter/ arbetsgivaravgifter.4.233f91f71260075abe8800020817.html. Accessed 26 Jan 2010
34. Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vagero M, Svensson K (2005) A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 66(1):111-121
35. Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J (2005) A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162(7):1351-1360
36. Tohen M, Goldberg JF, Gonzalez-Pinto Arrillaga AM, Azorin JM, Vieta E, Hardy-Bayle MC, Lawson WB, Emsley RA, Zhang F, Baker RW, Risser RC, Namjoshi MA, Evans AR, Breier A (2003) A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry 60(12):1218-1226
37. Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW (2003) Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 160(7):1263-1271
38. Wackerly DD, Mendenhall W, Schaeffer RL (1996) Mathematical statistics with applications, 5th edn. Duxbury Press, Belmont
39. Efron B, Tibshirani RJ (1993) An introduction to the bootstrap. Chapman and Hall, New York
40. Ekman M, Granström O, Omérov S, Jacob J, Landén M (2013) The societal cost of depression: evidence from 10,000 Swedish patients in psychiatric care. J Affect Disord [Epub ahead of print]
41. Ekman M, Granström O, Omérov S, Jacob J, Landén M (2013) The societal cost of schizophrenia in Sweden. J Ment Health Policy Econ 16(3):13-25
42. SCB (2009b) Tables on the population in Sweden 2009. Statistics Sweden. http://www.scb.se/statistik/-publikationer/BE0101-2009A01-BR-BE0110TAB.pdf. Accessed 2 Mar 2010
43. SCB (2010) The Swedish Health Accounts 2001-2008. Statistics Sweden (SCB). http://www.scb.se/Statistik/NR/NR0109/2008A01/SHA-tabeller-2001-2008prel- 20100331.xls. Accessed 14 Sept 2010
44. SCB (2010) Statistical Yearbook of Sweden 2010. Statistics Sweden (SCB). http://www.scb.se/Pages/PublishingCalendarViewInfo-259923.aspx?publobjid=11935. Accessed 14 Sept 2010
45. Akobundu E, Ju J, Blatt L, Mullins CD (2006) Cost-of-illness studies: a review of current methods. Pharmacoeconomics 24(9):869-890